1 bicyclo 2 2 1 hept 5 en 2 yl 1 phenyl 3 piperidin 1 yl propan 1 ol, alpha 5 norbornen 2 yl alpha phenyl 1 piperidinepropanol, alpha bicyclo 2 2 1 hept 5 en 2 yl alpha phenyl 1 piperidinepropanol
For use as an adjunct in the therapy of all forms of parkinsonism and control of extrapyramidal disorders secondary to neuroleptic drug therapy.